Furthermore, KIT -mutants were more likely to present with advanced disease at diagnosis (10.7%), although this difference did not reach statistical significance.
← all excerpts
Molecular Profiling of <i>KIT/PDGFRA</i>-Mutant and Wild-Type Gastrointestinal Stromal Tumors (GISTs) with Clinicopathological Correlation: An 18-Year Experience at a Tertiary Center in Kuwait.
1
—
—